| Listed site | cro | cro |
|---|
| Summary | Leading bioanalytical CRO with 45+ years of experience, supporting 315+ approved drugs through bioanalysis, biomarker, immunogenicity, flow cytometry, and clinical kitting services across US, EU, and Australia facilities. | Global life sciences and healthcare company providing diagnostic testing, drug development services, nonclinical research, and central laboratory services to biopharma companies, healthcare providers, and patients. |
|---|
| Services | - Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Biomarker Assays
- Immunogenicity Assays (ADA / NAb)
- Flow Cytometry Services
- Central Laboratory Services
- Immunology & Inflammation Services
- Virology Services
- Microbiology Services
- GLP Toxicology
- In Vivo PK / PD Studies
- Translational Research
- Discovery Research
| - Phase I Clinical Trials
- Phase II Clinical Trials
- Phase III Clinical Trials
- Phase IV / Post-Marketing
- Central Laboratory Services
- Clinical Operations
- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Ligand-Binding Bioanalysis (Large Molecule)
- Biomarker Assays
- Immunogenicity Assays (ADA / NAb)
- Flow Cytometry Services
- GLP Toxicology
- Safety Pharmacology
- In Vitro ADME / DMPK
- In Vitro Pharmacology
- Preclinical In Vitro Studies
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Genetic Toxicology
- Specialized & Large-Animal Models
- Translational Research
- Genomics & Sequencing Services
- Pathology & Histology Services
- Companion Diagnostics Development
- Biostatistics & Statistical Programming
- Data Management & eClinical
- US FDA Regulatory Strategy
- EU EMA Regulatory Strategy
- Regulatory Affairs
- Medical Writing
- Oncology Specialty Services
- Cardiovascular & Metabolic Specialty Services
- CNS Specialty Services
- Immunology & Inflammation Services
- Virology Services
- Microbiology Services
|
|---|
| Modalities | - Small Molecule
- Biologics (Monoclonal Antibodies)
- Antibody-Drug Conjugate (ADC)
- Cell Therapy
- Vaccine
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- Vaccine
- Radiopharmaceutical
|
|---|
| Indications | - Immunology
- Cardiovascular
- Dermatology
- Gastroenterology
- Infectious Disease
- Metabolic
- Neurology
- Oncology
- Ophthalmology
- Rare Disease
- Respiratory
- Nephrology
| - Oncology
- Neurology
- Cardiovascular
- Immunology
- Infectious Disease
- Rare Disease
- Metabolic
- Respiratory
- Psychiatry
- Women's Health
|
|---|
| Locations | - Kansas City, Kansas City, KS, USA
- Philadelphia, Philadelphia, PA, USA
- Lyon, Lyon, France
- Melbourne, Melbourne, Australia
- United States, US, United States
- Europe, EU, Europe
- Australia, Australia
| - Global Operations, Global
|
|---|
| Certifications | Data not yet provided. | Data not yet provided. |
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|